ouabain and valyltyrosine

ouabain has been researched along with valyltyrosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Axelband, F; Carmona, AK; Dias, J; Ferrão, FM; Lara, LS; Vieyra, A	1

Other Studies

1 other study(ies) available for ouabain and valyltyrosine

Article	Year
ANG-(3-4) inhibits renal Na+-ATPase in hypertensive rats through a mechanism that involves dissociation of ANG II receptors, heterodimers, and PKA. American journal of physiology. Renal physiology, 2014, Apr-15, Volume: 306, Issue:8 Topics: Adenosine Triphosphatases; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Cation Transport Proteins; Cyclic AMP-Dependent Protein Kinases; Dipeptides; Hypertension; Imidazoles; Kidney Tubules, Proximal; Ouabain; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sodium; Sodium-Potassium-Exchanging ATPase	2014

Article

Year

ANG-(3-4) inhibits renal Na+-ATPase in hypertensive rats through a mechanism that involves dissociation of ANG II receptors, heterodimers, and PKA.

American journal of physiology. Renal physiology, 2014, Apr-15, Volume: 306, Issue:8

Topics: Adenosine Triphosphatases; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Cation Transport Proteins; Cyclic AMP-Dependent Protein Kinases; Dipeptides; Hypertension; Imidazoles; Kidney Tubules, Proximal; Ouabain; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Sodium; Sodium-Potassium-Exchanging ATPase

2014